欢迎来到天天文库
浏览记录
ID:55319665
大小:671.29 KB
页数:5页
时间:2020-05-14
《局部晚期非小细胞肺癌同步放化疗前诱导化疗的临床研究.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、现代肿瘤医学2014年l2月第22卷第12期MODERNONCOLOGY,Dec.2014,VOL22,NO.12·2863·NarodSA.Bilateralbreastcancels[J].NatRevClinOncol,2014,3:2590.11(3):157—166.[14]WangT,IJiuH,ChenKX,eta1.Theriskfactorsandprognosisof[12]ShiYX,XiaQ,PengRJ,eta1.Comparisonofclinicopatholagicalbilateralprimarybreastcancer:Acomparati
2、vestudywithunilater-characteristicsandprognosesbetweenbilateralandunilateralalbreastcancer[J].OncolRes,2011,19(34):171—178.breastcancer[J].JCancerResClinOncol,2012,138(4):705—[15]ChenJJ,WangY,XueJY,eta1.Aclinic0path0localstudyof714.early—stagesynchronousbilateralbreastcancer:Aretrospective[1
3、3]ChenSF,DuCW,YangP,eta1.Themolecularandclinicopatho—evaluationandprospectivevalidationofpotentialriskfactors[J].logiccharacteristicsofbilateralbreastcancer[J].SciRep,2013,PLoSOne,2014,9(4):e95185.(编校:张西敏)局部晚期非小细胞肺癌同步放化疗前诱导化疗的临床研究吴伟,谢传华,李金伟,张群贵,康昭洵Clinicalresearchofinductionchemotherapybefor
4、econcurrentchemoradiotherapyinIo—caladvancednon——small——celllungcancerWuWei,XieChuanhua,LiJinwei,ZhangQungui,KangZhaoxunDepartmentofRadiotherapy,TumorHospitalofGanzhou,JiangxiGanzhou341000,China.【Abstract】0bjective:Toexplorethepatternofchemotherapycombinedwithconcurrentchemoradiotherapy(CRT)
5、forlocalyadvancednon—smallcelllungcancer(LANSCLC).Methods:Ninety—fourpatientswithLAN—SCLCbetweenMay2011andMay2013werereviewedandanalysed.A1lpatientsmeteligibilitycriteriaandweredi—videdintoA,B,Cgroups.GroupAreceivedconcurrent(CRT)atthestart,andthen4—6cyclesofadjuvantchemo—therapy.GroupBunder
6、went2cyclesofinductionchemotherapybeforeCRT,and2—4cyclesofadjuvantchemothera—PYafterCRT.GroupCexperienced4cyclesofinductionchemotherapybeforeCRTand0—2cyclesofadjuvantchem。otherapyafterCRT.Results:Therateoffollow—upwas95.7%.Objectiveresponses(ORR=CR+PR)inA,B,Cgroupswere67.7%,83.3%,66.7%,respe
7、ctively.Therewasnosignificantdiference(P=0.56)aboutORR.The1一yearand2一yearsurvivalofA,B,Cgroupswere70.3%,71.4%,78.5%and37.6%,36.9%,38.8%,respec—tively.Themediansurvivaltime(MST)was18.9months,17.9monthsand20.5months(P=0.763)forA,B,Cgroups,respectivel
此文档下载收益归作者所有